NeuCyte
PrivateLast Round
Grant
May 14, 2024
Total Funding Raised
$7.75M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
NeuCyte operates in Healthcare & Life Sciences and is based in Mountain View, California. Its latest recorded funding round was a Grant round in May 2024.
NeuCyte is a biotechnology company that has developed a target-identification and drug-discovery platform designed to create medicines for the treatment of neurological disorders.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NeuCyte Comparables
Compare NeuCyte with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BrainXell | 86% | |
| 28bio | 86% | |
| Tempo Bioscience, Inc. | 84% |
For institutional investors. Book with your work email.
NeuCyte Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 14, 2024 | ||||
| Grant | Aug 14, 2023 | ||||
| Series A | May 8, 2018 |
For institutional investors. Book with your work email.
NeuCyte Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Shenzhen Leaguer Tsing-Yuan Venture Capital Management | Series A |
| Co-Win Ventures | Series A |
| NIH RADx | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 12, 2026
Monthly visitors increased 2154% MoM, reaching 8.6K.
- Jul 20, 2026
Open roles increased from 0 to 21, representing 191% of headcount.
For institutional investors. Book with your work email.
NeuCyte Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about NeuCyte's valuation, stock price, and market status.
Is NeuCyte a public or private company?
NeuCyte is a private company.
What is the current stock price of NeuCyte?
NeuCyte is a private company, so its shares have no public market price. Caplight tracks NeuCyte's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is NeuCyte worth (valuation)?
Valuation information for NeuCyte is not publicly available.
Can I buy NeuCyte stock?
NeuCyte shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was NeuCyte's last funding round?
NeuCyte's most recent funding round was Grant on May 14, 2024.
Who are the main investors in NeuCyte?
Key investors in NeuCyte include Shenzhen Leaguer Tsing-Yuan Venture Capital Management, Co-Win Ventures.
Will NeuCyte IPO soon?
No public IPO plans have been announced for NeuCyte.
How can I track NeuCyte secondary market activity?
Caplight tracks bids, offers, and trades in NeuCyte's shares on secondary markets.